Masahiro Hatooka

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

Yuko Nagaoki, Hiroshi Aikata, Kana Daijyo et al. · Hepatology Research · 2017 · 146 citations

Medicine, Pharmacology, Pharmacotherapy +14

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large‐scale, long‐term cohort study

Yuko Nagaoki, Hiroshi Aikata, Norihito Nakano et al. · Journal of Gastroenterology and Hepatology · 2015 · 60 citations

Medicine, Infectious Diseases, Hepatology +16

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Yuko Nagaoki, Michio Imamura, Hiroshi Aikata et al. · PLoS ONE · 2017 · 57 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparison of hepatic arterial infusion chemotherapy <i>versus</i> sorafenib monotherapy in patients with advanced hepatocellular carcinoma

Tomokazu Kawaoka, Hiroshi Aikata, Hideyuki Hyogo et al. · Journal of Digestive Diseases · 2015 · 49 citations

Medicine, Oncology, Pharmacotherapy +16

Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis

Kenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata et al. · Oncology · 2018 · 49 citations

Medicine, Oncology, Pharmacotherapy +16